Markets:

Overview

News

Currencies

International

Treasuries

Cannara Biotech Inc (OP:LOVFF)

1.330 +0.032 (+2.47%)

Streaming Delayed Price Updated: 12:44 PM EST, Jan 14, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Cannara Biotech Inc

< Previous 1 2 Next >

This Week In Cannabis: Maryland Opens Lounges, DEA Wavers, Retail Trends Shift And More ↗

May 02, 2025

Lounges legalized, markets shift, DEA hedges on reform. Catch up on this week's key cannabis news in policy, business and science.

Via Benzinga

Topics Cannabis

Are You Missing Out On This NASDAQ-Listed Weed Stock? Low-Cost Model Meets European Demand ↗

December 05, 2024

Beyond Canada, this global cannabis company is focused on its international business, particularly in Germany, Australia, and the UK.

Via Benzinga

Topics Cannabis

Decibel Cannabis: One Acquisition Could Be The Key To Unlocking $20M In Cash Flow ↗

December 04, 2024

Decibel, a leading Canadian pre-roll franchise, may trade closer to larger market-cap cannabis stocks, according to analyst Pablo Zuanic.

Via Benzinga

Topics Cannabis

Canadian Cannabis Producer Cannara Reports 43% YoY Revenue Growth, Boosts Market Share And Profitability ↗

November 25, 2024

Vertically integrated cannabis producer Cannara Biotech Inc. (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0) announced on Monday its fourth quarter and full fiscal 2024 financial and operating results ended...

Via Benzinga

Topics Cannabis

Canada's Cannabis Market Goes Cold, Pot Prices Hit Bottom: Why Top Producers Are Losing Ground ↗

October 29, 2024

Amid this slowdown, certain products capture consumer interest, even as prices stabilize and competition intensifies.

Via Benzinga

Topics Cannabis

Cannara Biotech Reports 6% YoY Drop In Q3 Gross Profit, 22% Revenue Increase As It Enhances Sales Force And Infrastructure ↗

July 23, 2024

Vertically integrated cannabis company Cannara Biotech Inc. (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0) announced on Tuesday its fiscal third quarter 2024 financial and operating results for the three and...

Via Benzinga

Topics Cannabis

Cannabis Slowdown In Canada: Analyst Spotlights What Still Sells And Where The Money Is Going ↗

June 03, 2024

In a recent report, Pablo Zuanic of Zuanic & Associates analyzed trends in Canada's recreational cannabis market through May 2024. The report highlights a deceleration in market growth and notable...

Via Benzinga

Topics Cannabis

Cannara Biotech Reports 51% YoY Revenue Increase In Q2, Wider Net Loss ↗

May 01, 2024

Cannara Biotech Inc. announced on Monday its fiscal second quarter 2024 financial and operating results for the three and six-month periods ended Feb. 29, 2024. The company reported a 68%...

Via Benzinga

Topics Cannabis

This Cannabis Producer Reports It Is Able to Deliver Some Of The Highest Quality Product To Market At Some Of The Most Competitive Prices

December 20, 2023

--News Direct--

Via News Direct

Topics Cannabis

The 7 Most Undervalued Cannabis Stocks to Buy in December ↗

December 14, 2023

These seven cannabis stocks are either undervalued based on traditional metrics, or are undervalued relative to future potential.

Via InvestorPlace

Topics Cannabis

This Cannabis Producer Reports It Is Able to Deliver Some Of The Highest Quality Product To Market At Some Of The Most Competitive Prices ↗

December 07, 2023

Nicholas Sosiak, CFO of Cannara Biotech (TSXV: LOVE.V) (OTCQB: LOVFF) (FRA: 8CB) was recently interviewed by Benzinga.

Via Benzinga

Topics Cannabis

Bearish Sentiment Across The Cannabis Space - Check Full Movers For August 21, 2023 ↗

August 21, 2023

Via Benzinga

Topics Cannabis

7 Smoking-Hot 420 Stocks to Buy in 2023 ↗

August 17, 2023

A blaze of renewed bullishness may be just around the corner for these seven cannabis plays, making them top 420 stocks to buy.

Via InvestorPlace

Topics Cannabis

Cannabis Stock Movers For August 10, 2023 ↗

August 10, 2023

Via Benzinga

Topics Cannabis

Cannara Biotech Q3 FY23 Net Revenue Grows 57% YoY, What About Adjusted EBITDA? ↗

July 27, 2023

Cannara Biotech Inc.

Via Benzinga

Cannabis Stock Gainers And Losers From July 25, 2023 ↗

July 25, 2023

Via Benzinga

Cannabis Stock Gainers And Losers From August 4, 2023 ↗

August 04, 2023

Via Benzinga

Cannara Biotech Secures An Additional $10M In Non-Dilutive Capital With Its Lead Credit Provider, BMO Commercial Banking ↗

May 04, 2023

Cannara Biotech Inc.

Via Benzinga

Cannara Biotech Q2 FY23 Revenue Grows 76% YoY To $9.6M, Here Are The Details ↗

April 24, 2023

Cannara Biotech Inc. (OTCQB: LOVFF) (TSXV:LOVE) (FRA:8CB) released its fiscal second quarter 2023 financial results, revealing net revenue of CA$13 million ($9.6 million), a 76% increase, compared to...

Via Benzinga

Marijuana Stock Movers For August 1, 2023 ↗

August 01, 2023

Via Benzinga

Olymbec Investments Increases Its Ownership In Cannara Biotech ↗

February 10, 2023

Cannara Biotech Inc. (OTCQB: LOVFF) (TSXV:LOVE) (FRA:8CB) held its annual shareholder meeting on January 25, 2023.

Via Benzinga

Cannara Biotech Q1 Revenue Grows 57% YoY To $7.7M, What About Adjusted EBITDA? ↗

January 23, 2023

Cannara Biotech Inc. (OTCQB: LOVFF) (TSXV:LOVE) (FRA: 8CB) released its fiscal first quarter 2023 financial results for the three-month period ended November 30, 2022, revealing revenue of CA$10.3...

Via Benzinga

Cannabis Stock Movers For July 27, 2023 ↗

July 27, 2023

Via Benzinga

Cannara Biotech Q4 Revenue Grows 84% YoY To $8.9M ↗

November 28, 2022

Cannara Biotech Inc. (OTCQB: LOVFF) (TSXV:LOVE) (FRA:8CB) released its fiscal fourth quarter and fiscal year 2022 financial results for the three-month and full year periods ended August 31, 2022,...

Via Benzinga

Cannara Biotech Enters Into The British Columbia Cannabis Market And Launches New Products ↗

September 20, 2022

Cannara Biotech Inc. (OTCQB: LOVFF) (TSXV:LOVE) (FRA:8CB), a Quebec-based, vertically integrated producer of cannabis and derivative product offerings, entered into the British Columbia (BC) market.

Via Benzinga

Cannara Biotech Signs An Exclusive Brand Partnership With Exotic Genetix In Canada ↗

August 03, 2022

Cannara Biotech Inc. (OTCQB: LOVFF) (TSXV:LOVE) (FRA: 8CB) entered into an exclusive brand partnership with Exotic Genetix Ltd.

Via Benzinga

Cannara Biotech Revenue Grows 41% YoY, Here Are The Details ↗

July 27, 2022

Cannara Biotech Inc. (OTCQB: LOVFF) (TSXV:LOVE) (FRA:8CB) fiscal Q3 2022 revenue was $10.1 million, a 36% increase from the previous quarter and a 41% increase compared to Q3 2021.

Via Benzinga

Cannara Biotech Closes $50 Million Credit Facility Led By BMO Commercial Banking ↗

June 02, 2022

Cannara Biotech Inc. (OTCQB: LOVFF) (TSXV:LOVE) (FRA:8CB) has closed on a $50M credit facility led by BMO Commercial Banking.

Via Benzinga

Cannara Biotech Revenues Grew 229% To $7.4M In Q2 2022 YoY ↗

April 27, 2022

Cannara Biotech Inc. (OTCQB: LOVFF) (TSXV:LOVE) (FRA: 8CB) released its fiscal second quarter 2022 financial and operating results for the three and six-month periods ended February 28, 2022.

Via Benzinga

The Week In Cannabis: Isiah Thomas, Tilray, The DEA, Ohio, Mexico And More ↗

December 10, 2021

Below is a recap of the main news related to the cannabis industry and markets for the week of December 6, 2021.

Via Benzinga

Topics Cannabis

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.